Advances in the Management of FGIDs

Topic Information

This activity has been designed to meet the educational needs of gastroenterologists, physician assistants, and nurse practitioners involved in the management of FGIDs.

Educational Objectives

Upon completion of this activity, participants should be better able to:

Identify key advances in the management of functional gastrointestinal disorders

Incorporate new data on functional gastrointestinal disorders from 2013 major international meetings and the literature, as applicable, into daily practice

Credit Designation

Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this enduring activity is achieved by reading the material, reflecting on its implications in your practice, and completing the assessment component.

The estimated time to complete the activity is 1 hour.

Release Date: March 10, 2014Expiration Date: March 10, 2015 EXPIRED

Disclosure of Conflicts of Interest

All faculty and staff involved in the planning or presentation of continuing education activities sponsored/provided by Annenberg Center for Health Sciences at Eisenhower (ACHS) are required to disclose to the audience any real or apparent commercial financial affiliations related to the content
of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. Charles Willis, Director of Continuing Education (ACHS), consults for Pfizer, Inc.; all other staff at the Annenberg Center for Health Sciences at Eisenhower and The Gi Health Foundation has no relationships to disclose.

Learner Assurance Statement

The Annenberg Center for Health Sciences at Eisenhower is committed to resolving all conflicts of interest issues that could arise as a result of prospective faculty members’ significant relationships with drug or device manufacturer(s). The Annenberg Center for Health Sciences at Eisenhower is committed to retaining only those speakers with financial interests that can be reconciled with the goals and educational integrity of the CME activity.

Philip Schoenfeld, MD disclosed that he served as a consultant for and has participated on the speakers bureau and is an honorarium recipient for Salix Pharmaceuticals, Inc., Forest Laboratories and Ironwood Pharmaceuticals. Dr. Schoenfeld has an advisory board membership with Salix Pharmaceuticals, Inc.,
Forest Laboratories and Ironwood Pharmaceuticals. Dr. Schoenfeld has editorial board involvement in the Gastroenterology Journal. Dr. Schoenfeld is a partner at MD-Evidence, LLC.